Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Congenital Urogenital Anomaly”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02000219
What this trial is testing

Study to Evaluate the Efficacy and Safety of Oxabact (OC5) in Primary Hyperoxaluria Patients Who Are on Dialysis

Who this might be right for
Primary Hyperoxaluria
OxThera 12
Large-scale testing (Phase 3)Active Not RecruitingNCT04042402
What this trial is testing

Long Term Extension Study in Patients With Primary Hyperoxaluria

Who this might be right for
Primary Hyperoxaluria Type 1 (PH1)Primary Hyperoxaluria Type 2 (PH2)Kidney Diseases+3 more
Dicerna Pharmaceuticals, Inc., a Novo Nordisk company 75
Not applicableStudy completedNCT00004495
What this trial is testing

Randomized Study of Folic Acid Therapy for Hyperhomocysteinemia in Patients With End Stage Renal Disease Receiving Hemodialysis

Who this might be right for
End Stage Renal DiseaseHyperhomocysteinemia
Georgetown University 84
Early research (Phase 1)UnknownNCT05843305
What this trial is testing

BPI-452080 in Subjects With Solid Tumors

Who this might be right for
Solid TumorRenal Cell CarcinomaVon Hippel-Lindau Disease
Betta Pharmaceuticals Co., Ltd. 87
Post-approval studies (Phase 4)Study completedNCT03252223
What this trial is testing

Ovarian Response to Recombinant Follicle Stimulating Hormone in Women With PCOS

Who this might be right for
Polycystic Ovary SyndromeHealthyAnovulation+1 more
University of California, San Diego 33
Testing effectiveness (Phase 2)Study completedNCT00164229
What this trial is testing

Fetal Alcohol Syndrome: Socio-Cognitive Habilitation

Who this might be right for
Fetal Alcohol Syndrome
Centers for Disease Control and Prevention 100
Testing effectiveness (Phase 2)UnknownNCT00637637
What this trial is testing

External-Beam Radiation Therapy With or Without Indinavir and Ritonavir in Treating Patients With Brain Metastases

Who this might be right for
Cancer
Oncology Institute of Southern Switzerland 60
Not applicableLooking for participantsNCT06952777
What this trial is testing

Validation of Sensors for Long-term Non-Invasive Fetal Monitoring

Who this might be right for
Fetal Distress With Antenatal ProblemFetal Growth Retardation
University of Manchester 69
Testing effectiveness (Phase 2)Ended earlyNCT00589953
What this trial is testing

High-Dose Erythropoietin in Extremely Premature Infants to Prevent/Attenuate Brain Injury: A Phase II Study

Who this might be right for
Infant, PrematureErythropoietinBrain Injury+4 more
Atlantic Health System 22
Not applicableStudy completedNCT01914172
What this trial is testing

Health Needs of Patients With Kallmann Syndrome

Who this might be right for
Kallmann SyndromeCongenital Hypogonadotropic HypogonadismIdiopathic Hypogonadotropic Hypogonadism
Centre Hospitalier Universitaire Vaudois 249
Testing effectiveness (Phase 2)Looking for participantsNCT07536269
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Crinecerfont in Participants With Classic Congenital Adrenal Hyperplasia (CAH) Who Are Less Than 4 Years Old

Who this might be right for
Congenital Adrenal Hyperplasia
Neurocrine Switzerland GmbH 20
Early research (Phase 1)Study completedNCT00361049
What this trial is testing

Donor Mesenchymal Stem Cell Infusion in Treating Patients With Acute or Chronic Graft-Versus-Host Disease After Undergoing a Donor Stem Cell Transplant

Who this might be right for
Cancer
Case Comprehensive Cancer Center 49
Early research (Phase 1)Ended earlyNCT04895748
What this trial is testing

DFF332 as a Single Agent and in Combination With Everolimus & Immuno-Oncology Agents in Advanced/Relapsed Renal Cancer & Other Malignancies

Who this might be right for
Carcinoma, Renal Cell
Novartis Pharmaceuticals 40
Not applicableUnknownNCT02986126
What this trial is testing

Resilience Against Depression Disparities (Also Known as Resilience Education to Reduce Depression Disparities)

Who this might be right for
Depressive Symptoms
Bowen Chung, MD, MSHS 265
Post-approval studies (Phase 4)Study completedNCT00310908
What this trial is testing

Comparison Between Tramadol Hcl and Other Analgesics in the Treatment of Renal Colic

Who this might be right for
Renal Calculus
Hadassah Medical Organization 100
Not applicableLooking for participantsNCT04342026
What this trial is testing

Role of the Environment and Endocrine Disruptors in Child Cryptorchidism

Who this might be right for
Cryptorchidism
University Hospital, Montpellier 1,452
Not applicableUnknownNCT02627209
What this trial is testing

The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis

Who this might be right for
SarcoidosisTuberculosis
Ozlem Sahin 280
Not applicableStudy completedNCT03847753
What this trial is testing

Exploring the Comorbidity Between Mental Disorders and General Medical Conditions

Who this might be right for
Organic, Including Symptomatic, Mental DisordersSubstance UseSchizophrenia+38 more
University of Aarhus 5,940,299
Not applicableStudy completedNCT01783795
What this trial is testing

Dent Disease Mutation Genotyping

Who this might be right for
Dent Disease
Mayo Clinic 180
Not applicableStudy completedNCT00896272
What this trial is testing

Adaptation Among Adolescents and Adults With Klinefelter Syndrome

Who this might be right for
Klinefelter Syndrome
National Human Genome Research Institute (NHGRI) 302
Next Page